nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CYP2C19—Thalidomide—leprosy	0.0937	0.276	CbGbCtD
Zonisamide—CYP2C19—Rifampicin—leprosy	0.0907	0.267	CbGbCtD
Zonisamide—CYP2C19—Dapsone—leprosy	0.0749	0.221	CbGbCtD
Zonisamide—CYP3A4—Rifampicin—leprosy	0.0439	0.129	CbGbCtD
Zonisamide—CYP3A4—Dapsone—leprosy	0.0362	0.107	CbGbCtD
Zonisamide—Microcytic anaemia—Thalidomide—leprosy	0.029	0.075	CcSEcCtD
Zonisamide—SCN3A—spinal nerve—leprosy	0.0268	0.0979	CbGeAlD
Zonisamide—CA13—nerve—leprosy	0.0163	0.0596	CbGeAlD
Zonisamide—CA8—blood vessel—leprosy	0.015	0.0547	CbGeAlD
Zonisamide—SCN11A—peripheral nervous system—leprosy	0.0143	0.0524	CbGeAlD
Zonisamide—CA6—ear—leprosy	0.014	0.0513	CbGeAlD
Zonisamide—Cholangitis—Thalidomide—leprosy	0.0139	0.036	CcSEcCtD
Zonisamide—CA3—ear—leprosy	0.0133	0.0485	CbGeAlD
Zonisamide—SCN11A—nerve—leprosy	0.0112	0.0408	CbGeAlD
Zonisamide—Status epilepticus—Thalidomide—leprosy	0.0103	0.0265	CcSEcCtD
Zonisamide—Enuresis—Thalidomide—leprosy	0.00846	0.0219	CcSEcCtD
Zonisamide—Suicide attempt—Dapsone—leprosy	0.00832	0.0215	CcSEcCtD
Zonisamide—Circumoral paresthesia—Thalidomide—leprosy	0.00742	0.0192	CcSEcCtD
Zonisamide—Albuminuria—Dapsone—leprosy	0.00633	0.0163	CcSEcCtD
Zonisamide—SCN3B—tendon—leprosy	0.00518	0.0189	CbGeAlD
Zonisamide—Paraesthesia oral—Thalidomide—leprosy	0.00516	0.0133	CcSEcCtD
Zonisamide—Neck stiffness—Thalidomide—leprosy	0.00508	0.0131	CcSEcCtD
Zonisamide—Grand mal convulsion—Thalidomide—leprosy	0.00508	0.0131	CcSEcCtD
Zonisamide—SCN2B—nervous system—leprosy	0.00504	0.0184	CbGeAlD
Zonisamide—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00472	0.0122	CcSEcCtD
Zonisamide—CA1—nerve—leprosy	0.00469	0.0171	CbGeAlD
Zonisamide—Nuchal rigidity—Thalidomide—leprosy	0.00466	0.012	CcSEcCtD
Zonisamide—SCN1B—testis—leprosy	0.00465	0.017	CbGeAlD
Zonisamide—SCN1B—nervous system—leprosy	0.00456	0.0167	CbGeAlD
Zonisamide—CA13—tendon—leprosy	0.00452	0.0165	CbGeAlD
Zonisamide—CA10—testis—leprosy	0.00446	0.0163	CbGeAlD
Zonisamide—SCN4B—tendon—leprosy	0.0044	0.0161	CbGeAlD
Zonisamide—CA10—nervous system—leprosy	0.00437	0.016	CbGeAlD
Zonisamide—CA8—testis—leprosy	0.00437	0.016	CbGeAlD
Zonisamide—Vesiculobullous rash—Thalidomide—leprosy	0.00431	0.0111	CcSEcCtD
Zonisamide—SCN3B—testis—leprosy	0.00429	0.0157	CbGeAlD
Zonisamide—CA8—nervous system—leprosy	0.00429	0.0157	CbGeAlD
Zonisamide—Suicide attempt—Thalidomide—leprosy	0.00426	0.011	CcSEcCtD
Zonisamide—SCN3B—nervous system—leprosy	0.00421	0.0154	CbGeAlD
Zonisamide—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00416	0.0107	CcSEcCtD
Zonisamide—Myasthenia—Thalidomide—leprosy	0.00385	0.00994	CcSEcCtD
Zonisamide—MAOB—nerve—leprosy	0.00381	0.0139	CbGeAlD
Zonisamide—CA11—tendon—leprosy	0.00379	0.0139	CbGeAlD
Zonisamide—CA13—testis—leprosy	0.00374	0.0137	CbGeAlD
Zonisamide—CA13—nervous system—leprosy	0.00367	0.0134	CbGeAlD
Zonisamide—CA4—nerve—leprosy	0.00367	0.0134	CbGeAlD
Zonisamide—SCN4B—testis—leprosy	0.00365	0.0133	CbGeAlD
Zonisamide—SCN4B—nervous system—leprosy	0.00358	0.0131	CbGeAlD
Zonisamide—CACNA1I—testis—leprosy	0.00356	0.013	CbGeAlD
Zonisamide—Nystagmus—Thalidomide—leprosy	0.00338	0.00874	CcSEcCtD
Zonisamide—Psychotic disorder—Dapsone—leprosy	0.00335	0.00865	CcSEcCtD
Zonisamide—MAOA—nerve—leprosy	0.00325	0.0119	CbGeAlD
Zonisamide—Albuminuria—Thalidomide—leprosy	0.00324	0.00837	CcSEcCtD
Zonisamide—Neuritis—Thalidomide—leprosy	0.00324	0.00837	CcSEcCtD
Zonisamide—CA11—testis—leprosy	0.00314	0.0115	CbGeAlD
Zonisamide—Amblyopia—Thalidomide—leprosy	0.00313	0.00809	CcSEcCtD
Zonisamide—CA11—nervous system—leprosy	0.00308	0.0113	CbGeAlD
Zonisamide—Hyperaesthesia—Thalidomide—leprosy	0.00308	0.00796	CcSEcCtD
Zonisamide—Rash pustular—Thalidomide—leprosy	0.00303	0.00783	CcSEcCtD
Zonisamide—Muscular weakness—Dapsone—leprosy	0.00302	0.00781	CcSEcCtD
Zonisamide—Influenza—Dapsone—leprosy	0.00296	0.00766	CcSEcCtD
Zonisamide—Petechiae—Thalidomide—leprosy	0.00294	0.00759	CcSEcCtD
Zonisamide—Pancreatitis—Dapsone—leprosy	0.00291	0.00751	CcSEcCtD
Zonisamide—Blood disorder—Thalidomide—leprosy	0.00289	0.00748	CcSEcCtD
Zonisamide—Apnoea—Thalidomide—leprosy	0.00285	0.00737	CcSEcCtD
Zonisamide—Amenorrhoea—Thalidomide—leprosy	0.00275	0.00711	CcSEcCtD
Zonisamide—Jaundice cholestatic—Thalidomide—leprosy	0.00275	0.00711	CcSEcCtD
Zonisamide—Accidental injury—Thalidomide—leprosy	0.00273	0.00706	CcSEcCtD
Zonisamide—Musculoskeletal stiffness—Thalidomide—leprosy	0.0027	0.00696	CcSEcCtD
Zonisamide—Neuropathy peripheral—Dapsone—leprosy	0.00259	0.00669	CcSEcCtD
Zonisamide—Dyskinesia—Thalidomide—leprosy	0.00257	0.00665	CcSEcCtD
Zonisamide—Leukocytosis—Thalidomide—leprosy	0.00257	0.00665	CcSEcCtD
Zonisamide—SCN11A—nervous system—leprosy	0.00251	0.00918	CbGeAlD
Zonisamide—Gait disturbance—Thalidomide—leprosy	0.00248	0.0064	CcSEcCtD
Zonisamide—CA12—eye—leprosy	0.00247	0.00904	CbGeAlD
Zonisamide—Coordination abnormal—Thalidomide—leprosy	0.00246	0.00636	CcSEcCtD
Zonisamide—Hepatocellular injury—Thalidomide—leprosy	0.00242	0.00625	CcSEcCtD
Zonisamide—Pulmonary embolism—Thalidomide—leprosy	0.00242	0.00625	CcSEcCtD
Zonisamide—CACNA1G—nervous system—leprosy	0.0024	0.00876	CbGeAlD
Zonisamide—Pharyngitis—Dapsone—leprosy	0.00235	0.00608	CcSEcCtD
Zonisamide—Depressed level of consciousness—Thalidomide—leprosy	0.00233	0.00603	CcSEcCtD
Zonisamide—Colitis—Thalidomide—leprosy	0.00232	0.006	CcSEcCtD
Zonisamide—CA3—tendon—leprosy	0.00231	0.00846	CbGeAlD
Zonisamide—Blood urea increased—Thalidomide—leprosy	0.00228	0.0059	CcSEcCtD
Zonisamide—Aplastic anaemia—Thalidomide—leprosy	0.00227	0.00586	CcSEcCtD
Zonisamide—Neuropathy—Thalidomide—leprosy	0.00227	0.00586	CcSEcCtD
Zonisamide—Cramps of lower extremities—Thalidomide—leprosy	0.00222	0.00574	CcSEcCtD
Zonisamide—CA9—tendon—leprosy	0.00221	0.0081	CbGeAlD
Zonisamide—Tinnitus—Dapsone—leprosy	0.00221	0.00571	CcSEcCtD
Zonisamide—Oesophagitis—Thalidomide—leprosy	0.00221	0.00571	CcSEcCtD
Zonisamide—Rash maculo-papular—Thalidomide—leprosy	0.0022	0.00568	CcSEcCtD
Zonisamide—Gynaecomastia—Thalidomide—leprosy	0.00216	0.00559	CcSEcCtD
Zonisamide—Hypertonia—Thalidomide—leprosy	0.00212	0.00548	CcSEcCtD
Zonisamide—Hyperkinesia—Thalidomide—leprosy	0.00211	0.00545	CcSEcCtD
Zonisamide—CA14—tendon—leprosy	0.0021	0.00768	CbGeAlD
Zonisamide—Euphoric mood—Thalidomide—leprosy	0.00208	0.00537	CcSEcCtD
Zonisamide—AOX1—eye—leprosy	0.00206	0.00754	CbGeAlD
Zonisamide—SCN9A—tendon—leprosy	0.00206	0.00752	CbGeAlD
Zonisamide—Lymphadenopathy—Thalidomide—leprosy	0.00206	0.00531	CcSEcCtD
Zonisamide—Thrombophlebitis—Thalidomide—leprosy	0.00203	0.00524	CcSEcCtD
Zonisamide—Gastroenteritis—Thalidomide—leprosy	0.00198	0.00512	CcSEcCtD
Zonisamide—Deafness—Thalidomide—leprosy	0.00196	0.00507	CcSEcCtD
Zonisamide—CA1—eye—leprosy	0.00196	0.00716	CbGeAlD
Zonisamide—Eczema—Thalidomide—leprosy	0.00195	0.00505	CcSEcCtD
Zonisamide—CA3—testis—leprosy	0.00192	0.007	CbGeAlD
Zonisamide—Injury—Thalidomide—leprosy	0.00191	0.00493	CcSEcCtD
Zonisamide—Libido decreased—Thalidomide—leprosy	0.00189	0.00489	CcSEcCtD
Zonisamide—CA3—nervous system—leprosy	0.00188	0.00687	CbGeAlD
Zonisamide—Amnesia—Thalidomide—leprosy	0.00187	0.00483	CcSEcCtD
Zonisamide—Vertigo—Dapsone—leprosy	0.00185	0.00479	CcSEcCtD
Zonisamide—Atrial fibrillation—Thalidomide—leprosy	0.00185	0.00478	CcSEcCtD
Zonisamide—Dermatitis bullous—Thalidomide—leprosy	0.00184	0.00474	CcSEcCtD
Zonisamide—SCN4A—tendon—leprosy	0.00184	0.00671	CbGeAlD
Zonisamide—CA9—testis—leprosy	0.00183	0.0067	CbGeAlD
Zonisamide—Arthritis—Thalidomide—leprosy	0.00181	0.00467	CcSEcCtD
Zonisamide—Cough—Dapsone—leprosy	0.0018	0.00465	CcSEcCtD
Zonisamide—Cardiac failure—Thalidomide—leprosy	0.0018	0.00465	CcSEcCtD
Zonisamide—Hypoglycaemia—Thalidomide—leprosy	0.0018	0.00465	CcSEcCtD
Zonisamide—Cerebrovascular accident—Thalidomide—leprosy	0.00179	0.00463	CcSEcCtD
Zonisamide—Hyponatraemia—Thalidomide—leprosy	0.00176	0.00455	CcSEcCtD
Zonisamide—Osteoarthritis—Thalidomide—leprosy	0.00176	0.00453	CcSEcCtD
Zonisamide—Diplopia—Thalidomide—leprosy	0.00176	0.00453	CcSEcCtD
Zonisamide—Disturbance in sexual arousal—Thalidomide—leprosy	0.00174	0.0045	CcSEcCtD
Zonisamide—Affect lability—Thalidomide—leprosy	0.00173	0.00446	CcSEcCtD
Zonisamide—Psychotic disorder—Thalidomide—leprosy	0.00171	0.00443	CcSEcCtD
Zonisamide—SCN9A—testis—leprosy	0.0017	0.00623	CbGeAlD
Zonisamide—Face oedema—Thalidomide—leprosy	0.00169	0.00438	CcSEcCtD
Zonisamide—Mood swings—Thalidomide—leprosy	0.00166	0.0043	CcSEcCtD
Zonisamide—Ataxia—Thalidomide—leprosy	0.00165	0.00426	CcSEcCtD
Zonisamide—Tachycardia—Dapsone—leprosy	0.00164	0.00425	CcSEcCtD
Zonisamide—Blood creatinine increased—Thalidomide—leprosy	0.00164	0.00425	CcSEcCtD
Zonisamide—Dehydration—Thalidomide—leprosy	0.00163	0.00422	CcSEcCtD
Zonisamide—Liver function test abnormal—Thalidomide—leprosy	0.00162	0.00419	CcSEcCtD
Zonisamide—Dry skin—Thalidomide—leprosy	0.00161	0.00416	CcSEcCtD
Zonisamide—Hypokalaemia—Thalidomide—leprosy	0.0016	0.00413	CcSEcCtD
Zonisamide—CACNA1H—testis—leprosy	0.0016	0.00584	CbGeAlD
Zonisamide—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00158	0.00408	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00158	0.00408	CcSEcCtD
Zonisamide—CACNA1H—nervous system—leprosy	0.00157	0.00573	CbGeAlD
Zonisamide—Muscular weakness—Thalidomide—leprosy	0.00155	0.004	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Thalidomide—leprosy	0.00155	0.004	CcSEcCtD
Zonisamide—Insomnia—Dapsone—leprosy	0.00152	0.00394	CcSEcCtD
Zonisamide—SCN4A—testis—leprosy	0.00152	0.00556	CbGeAlD
Zonisamide—Influenza—Thalidomide—leprosy	0.00152	0.00392	CcSEcCtD
Zonisamide—Dysphagia—Thalidomide—leprosy	0.00152	0.00392	CcSEcCtD
Zonisamide—Eosinophilia—Thalidomide—leprosy	0.0015	0.00388	CcSEcCtD
Zonisamide—SCN4A—nervous system—leprosy	0.00149	0.00545	CbGeAlD
Zonisamide—Pancreatitis—Thalidomide—leprosy	0.00149	0.00384	CcSEcCtD
Zonisamide—CA5B—tendon—leprosy	0.00147	0.00537	CbGeAlD
Zonisamide—Pancytopenia—Thalidomide—leprosy	0.00144	0.00372	CcSEcCtD
Zonisamide—SCN1A—nervous system—leprosy	0.00144	0.00526	CbGeAlD
Zonisamide—SCN3A—tendon—leprosy	0.00143	0.00522	CbGeAlD
Zonisamide—Pollakiuria—Thalidomide—leprosy	0.0014	0.00362	CcSEcCtD
Zonisamide—Erectile dysfunction—Thalidomide—leprosy	0.0014	0.00361	CcSEcCtD
Zonisamide—Weight increased—Thalidomide—leprosy	0.00138	0.00357	CcSEcCtD
Zonisamide—Gastrointestinal pain—Dapsone—leprosy	0.00138	0.00356	CcSEcCtD
Zonisamide—Weight decreased—Thalidomide—leprosy	0.00137	0.00355	CcSEcCtD
Zonisamide—AOX1—tendon—leprosy	0.00137	0.005	CbGeAlD
Zonisamide—Pneumonia—Thalidomide—leprosy	0.00136	0.00351	CcSEcCtD
Zonisamide—Depression—Thalidomide—leprosy	0.00135	0.00348	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00134	0.00346	CcSEcCtD
Zonisamide—Abdominal pain—Dapsone—leprosy	0.00133	0.00344	CcSEcCtD
Zonisamide—Body temperature increased—Dapsone—leprosy	0.00133	0.00344	CcSEcCtD
Zonisamide—CA12—nervous system—leprosy	0.00133	0.00487	CbGeAlD
Zonisamide—Renal failure—Thalidomide—leprosy	0.00133	0.00343	CcSEcCtD
Zonisamide—Neuropathy peripheral—Thalidomide—leprosy	0.00133	0.00343	CcSEcCtD
Zonisamide—SCN2A—nervous system—leprosy	0.00132	0.00483	CbGeAlD
Zonisamide—Stomatitis—Thalidomide—leprosy	0.00132	0.00341	CcSEcCtD
Zonisamide—Conjunctivitis—Thalidomide—leprosy	0.00131	0.0034	CcSEcCtD
Zonisamide—Sweating—Thalidomide—leprosy	0.0013	0.00335	CcSEcCtD
Zonisamide—Haematuria—Thalidomide—leprosy	0.00129	0.00333	CcSEcCtD
Zonisamide—CA2—eye—leprosy	0.00127	0.00464	CbGeAlD
Zonisamide—Agranulocytosis—Thalidomide—leprosy	0.00126	0.00326	CcSEcCtD
Zonisamide—Bradycardia—Thalidomide—leprosy	0.00124	0.00319	CcSEcCtD
Zonisamide—Rhinitis—Thalidomide—leprosy	0.00122	0.00314	CcSEcCtD
Zonisamide—CA5B—testis—leprosy	0.00122	0.00445	CbGeAlD
Zonisamide—Pharyngitis—Thalidomide—leprosy	0.00121	0.00311	CcSEcCtD
Zonisamide—Urinary tract disorder—Thalidomide—leprosy	0.0012	0.0031	CcSEcCtD
Zonisamide—Oedema peripheral—Thalidomide—leprosy	0.0012	0.00309	CcSEcCtD
Zonisamide—CA5B—nervous system—leprosy	0.00119	0.00437	CbGeAlD
Zonisamide—Urethral disorder—Thalidomide—leprosy	0.00119	0.00307	CcSEcCtD
Zonisamide—SCN3A—testis—leprosy	0.00118	0.00432	CbGeAlD
Zonisamide—SCN3A—nervous system—leprosy	0.00116	0.00424	CbGeAlD
Zonisamide—SCN5A—nervous system—leprosy	0.00116	0.00423	CbGeAlD
Zonisamide—Erythema multiforme—Thalidomide—leprosy	0.00115	0.00297	CcSEcCtD
Zonisamide—Eye disorder—Thalidomide—leprosy	0.00113	0.00293	CcSEcCtD
Zonisamide—Tinnitus—Thalidomide—leprosy	0.00113	0.00292	CcSEcCtD
Zonisamide—AOX1—testis—leprosy	0.00113	0.00414	CbGeAlD
Zonisamide—CA2—skin of body—leprosy	0.0011	0.00404	CbGeAlD
Zonisamide—Immune system disorder—Thalidomide—leprosy	0.0011	0.00283	CcSEcCtD
Zonisamide—Mediastinal disorder—Thalidomide—leprosy	0.00109	0.00283	CcSEcCtD
Zonisamide—Alopecia—Thalidomide—leprosy	0.00107	0.00277	CcSEcCtD
Zonisamide—Vomiting—Dapsone—leprosy	0.00107	0.00277	CcSEcCtD
Zonisamide—Mental disorder—Thalidomide—leprosy	0.00106	0.00275	CcSEcCtD
Zonisamide—Malnutrition—Thalidomide—leprosy	0.00106	0.00273	CcSEcCtD
Zonisamide—Headache—Dapsone—leprosy	0.00106	0.00273	CcSEcCtD
Zonisamide—CA1—nervous system—leprosy	0.00105	0.00385	CbGeAlD
Zonisamide—MAOB—tendon—leprosy	0.00105	0.00385	CbGeAlD
Zonisamide—Flatulence—Thalidomide—leprosy	0.00104	0.00269	CcSEcCtD
Zonisamide—Tension—Thalidomide—leprosy	0.00104	0.00268	CcSEcCtD
Zonisamide—Dysgeusia—Thalidomide—leprosy	0.00104	0.00267	CcSEcCtD
Zonisamide—Nervousness—Thalidomide—leprosy	0.00103	0.00265	CcSEcCtD
Zonisamide—Muscle spasms—Thalidomide—leprosy	0.00102	0.00263	CcSEcCtD
Zonisamide—CA4—tendon—leprosy	0.00101	0.00371	CbGeAlD
Zonisamide—Nausea—Dapsone—leprosy	0.001	0.00259	CcSEcCtD
Zonisamide—Tremor—Thalidomide—leprosy	0.00099	0.00256	CcSEcCtD
Zonisamide—Ill-defined disorder—Thalidomide—leprosy	0.000981	0.00253	CcSEcCtD
Zonisamide—Anaemia—Thalidomide—leprosy	0.000977	0.00252	CcSEcCtD
Zonisamide—Agitation—Thalidomide—leprosy	0.000971	0.00251	CcSEcCtD
Zonisamide—Malaise—Thalidomide—leprosy	0.000953	0.00246	CcSEcCtD
Zonisamide—Vertigo—Thalidomide—leprosy	0.00095	0.00245	CcSEcCtD
Zonisamide—Syncope—Thalidomide—leprosy	0.000948	0.00245	CcSEcCtD
Zonisamide—Leukopenia—Thalidomide—leprosy	0.000946	0.00244	CcSEcCtD
Zonisamide—Palpitations—Thalidomide—leprosy	0.000934	0.00241	CcSEcCtD
Zonisamide—Loss of consciousness—Thalidomide—leprosy	0.000929	0.0024	CcSEcCtD
Zonisamide—Cough—Thalidomide—leprosy	0.000922	0.00238	CcSEcCtD
Zonisamide—Convulsion—Thalidomide—leprosy	0.000916	0.00237	CcSEcCtD
Zonisamide—Hypertension—Thalidomide—leprosy	0.000912	0.00236	CcSEcCtD
Zonisamide—Arthralgia—Thalidomide—leprosy	0.0009	0.00232	CcSEcCtD
Zonisamide—Chest pain—Thalidomide—leprosy	0.0009	0.00232	CcSEcCtD
Zonisamide—Myalgia—Thalidomide—leprosy	0.0009	0.00232	CcSEcCtD
Zonisamide—MAOA—tendon—leprosy	0.000899	0.00328	CbGeAlD
Zonisamide—Anxiety—Thalidomide—leprosy	0.000897	0.00232	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000894	0.00231	CcSEcCtD
Zonisamide—Discomfort—Thalidomide—leprosy	0.000889	0.0023	CcSEcCtD
Zonisamide—Dry mouth—Thalidomide—leprosy	0.00088	0.00227	CcSEcCtD
Zonisamide—MAOB—testis—leprosy	0.000872	0.00319	CbGeAlD
Zonisamide—Confusional state—Thalidomide—leprosy	0.00087	0.00225	CcSEcCtD
Zonisamide—Oedema—Thalidomide—leprosy	0.000863	0.00223	CcSEcCtD
Zonisamide—Infection—Thalidomide—leprosy	0.000857	0.00221	CcSEcCtD
Zonisamide—MAOB—nervous system—leprosy	0.000856	0.00313	CbGeAlD
Zonisamide—Shock—Thalidomide—leprosy	0.000849	0.00219	CcSEcCtD
Zonisamide—Nervous system disorder—Thalidomide—leprosy	0.000846	0.00219	CcSEcCtD
Zonisamide—Thrombocytopenia—Thalidomide—leprosy	0.000845	0.00218	CcSEcCtD
Zonisamide—Tachycardia—Thalidomide—leprosy	0.000842	0.00217	CcSEcCtD
Zonisamide—CA2—tendon—leprosy	0.000841	0.00307	CbGeAlD
Zonisamide—CA4—testis—leprosy	0.00084	0.00307	CbGeAlD
Zonisamide—Skin disorder—Thalidomide—leprosy	0.000838	0.00216	CcSEcCtD
Zonisamide—Hyperhidrosis—Thalidomide—leprosy	0.000834	0.00215	CcSEcCtD
Zonisamide—CA4—nervous system—leprosy	0.000824	0.00301	CbGeAlD
Zonisamide—Anorexia—Thalidomide—leprosy	0.000822	0.00212	CcSEcCtD
Zonisamide—Hypotension—Thalidomide—leprosy	0.000806	0.00208	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Thalidomide—leprosy	0.000786	0.00203	CcSEcCtD
Zonisamide—Insomnia—Thalidomide—leprosy	0.00078	0.00202	CcSEcCtD
Zonisamide—Paraesthesia—Thalidomide—leprosy	0.000775	0.002	CcSEcCtD
Zonisamide—Dyspnoea—Thalidomide—leprosy	0.000769	0.00199	CcSEcCtD
Zonisamide—Somnolence—Thalidomide—leprosy	0.000767	0.00198	CcSEcCtD
Zonisamide—Dyspepsia—Thalidomide—leprosy	0.000759	0.00196	CcSEcCtD
Zonisamide—Decreased appetite—Thalidomide—leprosy	0.00075	0.00194	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Thalidomide—leprosy	0.000745	0.00192	CcSEcCtD
Zonisamide—MAOA—testis—leprosy	0.000744	0.00272	CbGeAlD
Zonisamide—Fatigue—Thalidomide—leprosy	0.000744	0.00192	CcSEcCtD
Zonisamide—Constipation—Thalidomide—leprosy	0.000738	0.00191	CcSEcCtD
Zonisamide—MAOA—nervous system—leprosy	0.00073	0.00267	CbGeAlD
Zonisamide—Feeling abnormal—Thalidomide—leprosy	0.000711	0.00184	CcSEcCtD
Zonisamide—Gastrointestinal pain—Thalidomide—leprosy	0.000705	0.00182	CcSEcCtD
Zonisamide—CA2—testis—leprosy	0.000696	0.00255	CbGeAlD
Zonisamide—Urticaria—Thalidomide—leprosy	0.000685	0.00177	CcSEcCtD
Zonisamide—CA2—nervous system—leprosy	0.000684	0.0025	CbGeAlD
Zonisamide—Body temperature increased—Thalidomide—leprosy	0.000682	0.00176	CcSEcCtD
Zonisamide—Abdominal pain—Thalidomide—leprosy	0.000682	0.00176	CcSEcCtD
Zonisamide—Hypersensitivity—Thalidomide—leprosy	0.000636	0.00164	CcSEcCtD
Zonisamide—Asthenia—Thalidomide—leprosy	0.000619	0.0016	CcSEcCtD
Zonisamide—Pruritus—Thalidomide—leprosy	0.00061	0.00158	CcSEcCtD
Zonisamide—Diarrhoea—Thalidomide—leprosy	0.00059	0.00152	CcSEcCtD
Zonisamide—Dizziness—Thalidomide—leprosy	0.00057	0.00147	CcSEcCtD
Zonisamide—Vomiting—Thalidomide—leprosy	0.000548	0.00142	CcSEcCtD
Zonisamide—Rash—Thalidomide—leprosy	0.000544	0.00141	CcSEcCtD
Zonisamide—Dermatitis—Thalidomide—leprosy	0.000543	0.0014	CcSEcCtD
Zonisamide—Headache—Thalidomide—leprosy	0.00054	0.0014	CcSEcCtD
Zonisamide—Nausea—Thalidomide—leprosy	0.000512	0.00132	CcSEcCtD
Zonisamide—CYP3A4—nervous system—leprosy	0.000441	0.00161	CbGeAlD
